How to assess the role of Pt and Zn in the nephrotoxicity of Pt anti-cancer drugs?: An investigation combining mXRF and statistical analysis. Part II: Clinical application - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Comptes Rendus. Chimie Année : 2016

How to assess the role of Pt and Zn in the nephrotoxicity of Pt anti-cancer drugs?: An investigation combining mXRF and statistical analysis. Part II: Clinical application

Solenn Reguer
  • Fonction : Auteur

Résumé

In this contribution, an approach developed previously for mice is used for human biopsy. In the case of patient 1, Pt detection is performed 6 days after the last oxaliplatin infusion, while for patient 2, the biopsy was performed more than 15 days after his first platin infusion and several dialysis. Even for these biological samples, experiments show that synchrotron mediated mXRF is a suitable tool to detect Pt in kidney biopsy, and thus probably for any organ exposed to Pt. Therefore, mXRF could also be of major interest to decipher the mechanism beyond Pt induced neurotoxicity, ototoxicity on human biopsy. Pharmacoavailability of chemotherapies is a major concern because some treatment failures are explained by poor tumor penetration of the active molecule. mXRF could be an elegant way to map the distribution of Pt inside cancerous cells at the micrometer scale. Pt and Zn are only two of the numerous trace elements that mXRF can detect; heavy metal intoxication diagnosis and the toxicity mechanism probably could also benefit from this innovative technique.

Domaines

Chimie
Fichier principal
Vignette du fichier
how.pdf (542.8 Ko) Télécharger le fichier
Origine : Publication financée par une institution
Loading...

Dates et versions

hal-01297887 , version 1 (05-04-2016)

Licence

Paternité

Identifiants

Citer

Emmanuel Esteve, Dominique Bazin, Chantal Jouanneau, Stephan Rouzière, Aurélien Bataille, et al.. How to assess the role of Pt and Zn in the nephrotoxicity of Pt anti-cancer drugs?: An investigation combining mXRF and statistical analysis. Part II: Clinical application. Comptes Rendus. Chimie, 2016, 19 (11-12), pp.1586-1589. ⟨10.1016/j.crci.2016.02.015⟩. ⟨hal-01297887⟩
255 Consultations
232 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More